C19orf12
Basic information
Region (hg38): 19:29698937-29715789
Previous symbols: [ "SPG43" ]
Links
Phenotypes
GenCC
Source:
- neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AD
- neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
- neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
- neurodegeneration with brain iron accumulation 4 (Definitive), mode of inheritance: Semidominant
- neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
- neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
- hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
- neurodegeneration with brain iron accumulation 4 (Moderate), mode of inheritance: AD
- neurodegeneration with brain iron accumulation 4 (Definitive), mode of inheritance: AR
- neurodegeneration with brain iron accumulation 4 (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodegeneration with brain iron accumulation 4; Spastic paraplegia 43 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 21981780; 22508347; 23269600; 23447832; 23494994; 23521069; 23857908; 26187298; 29295770; 30298423; 31087512 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodegeneration with brain iron accumulation 4 (2 variants)
- Spastic ataxia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C19orf12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 29 | 32 | ||||
missense | 55 | 63 | ||||
nonsense | 2 | |||||
start loss | 2 | |||||
frameshift | 16 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 84 | 33 | 41 | 159 | ||
Total | 3 | 16 | 150 | 63 | 43 |
Highest pathogenic variant AF is 0.00000657
Variants in C19orf12
This is a list of pathogenic ClinVar variants found in the C19orf12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-29698967-C-T | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 13, 2018) | ||
19-29699015-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 13, 2018) | ||
19-29699040-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699141-G-A | Neurodegeneration with brain iron accumulation 4 | Benign (Jan 13, 2018) | ||
19-29699192-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699194-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699194-G-T | Neurodegeneration with brain iron accumulation 4 | Benign (Jan 13, 2018) | ||
19-29699220-C-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699249-C-T | Neurodegeneration with brain iron accumulation 4 | Benign (Jan 12, 2018) | ||
19-29699295-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699309-T-TA | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jun 14, 2016) | ||
19-29699312-A-T | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699312-A-AT | Neurodegeneration with brain iron accumulation 4 | Likely benign (Jun 14, 2016) | ||
19-29699340-G-A | Neurodegeneration with brain iron accumulation 4 | Benign (Jan 13, 2018) | ||
19-29699355-C-T | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Apr 27, 2017) | ||
19-29699360-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699375-C-T | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699376-G-A | Neurodegeneration with brain iron accumulation 4 | Benign (Jan 13, 2018) | ||
19-29699398-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 13, 2018) | ||
19-29699408-A-G | Neurodegeneration with brain iron accumulation 4 | Likely benign (Jan 12, 2018) | ||
19-29699412-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699418-G-C | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 13, 2018) | ||
19-29699424-A-C | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) | ||
19-29699440-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 13, 2018) | ||
19-29699470-G-A | Neurodegeneration with brain iron accumulation 4 | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C19orf12 | protein_coding | protein_coding | ENST00000392278 | 3 | 14644 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.344 | 0.604 | 125714 | 0 | 32 | 125746 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.390 | 84 | 94.7 | 0.887 | 0.00000631 | 976 |
Missense in Polyphen | 17 | 20.886 | 0.81395 | 265 | ||
Synonymous | -0.785 | 52 | 45.3 | 1.15 | 0.00000379 | 322 |
Loss of Function | 1.52 | 1 | 4.46 | 0.224 | 1.92e-7 | 55 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000223 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000188 | 0.000185 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. NBIA4 results in speech difficulty, extrapyramidal signs, oromandibular and generalized dystonia, and parkinsonism. Most patients have progressive involvement of the corticospinal tract, with spasticity, hyperreflexia, and extensor plantar responses. {ECO:0000269|PubMed:21981780, ECO:0000269|PubMed:22508347, ECO:0000269|PubMed:22584950, ECO:0000269|PubMed:22704260, ECO:0000269|PubMed:23269600, ECO:0000269|PubMed:23278385, ECO:0000269|PubMed:23521069, ECO:0000269|PubMed:23857908, ECO:0000269|PubMed:25592411, ECO:0000269|PubMed:26136767, ECO:0000269|PubMed:26187298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spastic paraplegia 43, autosomal recessive (SPG43) [MIM:615043]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SP43 is characterized by childhood onset of progressive spasticity affecting the lower and upper limbs. {ECO:0000269|PubMed:23857908}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.0410
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.06
Haploinsufficiency Scores
- pHI
- 0.119
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- 1600014C10Rik
- Phenotype
Gene ontology
- Biological process
- autophagy;apoptotic process;response to oxidative stress;mitochondrial calcium ion homeostasis
- Cellular component
- mitochondrion;endoplasmic reticulum;cytosol;integral component of membrane;mitochondrial membrane
- Molecular function